Fundraising FoxGliocart
1 known investors
Find your way into Gliocart
Sign up to find every way you can get introduced to Gliocart
- Your email: who you already know at Gliocart, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gliocart team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.
Investors · 1
Frequently asked questions
- What does Gliocart do?
- GlioCART develops a dual-action CAR-T cell therapy for glioblastoma that targets tumor cells while reprogramming tumor-supporting myeloid cells into active immune effectors. The company aims to extend CAR-T therapy to solid tumors and other myeloid-driven cancers.
- Who are Gliocart's investors?
- Gliocart's investors include Kickfund.